Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net loss	$ (3,183)	$ (3,069)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	60	107
Share-based compensation	203	574
Shares issued to vendors in exchange for services	35
Amortization of right-of-use asset	12	15
Non-cash interest	475	463
Amortization of debt premium and debt issuance costs, net	(8)	(9)
Changes in operating assets and liabilities:
Accounts receivable and unbilled receivables	(456)	664
Prepaid expenses and other assets	56	151
Accounts payable	2,234	(373)
Accrued expenses	408	(679)
Accrued fiduciary obligations	(146)	1,919
Operating lease liabilities	(62)	(59)
Due to related party	8
Other liabilities	(113)	181
Net cash used in operating activities	(477)	(115)
Cash flows from investing activities:
Proceeds from sale of business unit		500
Net cash provided by investing activities		500
Cash flows from financing activities:
Proceeds from issuance of related party promissory notes	660
Proceeds from issuance of convertible debentures (Note 7)		3,000
Payments of debt issuance costs		(162)
Payments on convertible debentures (Note 7)	(500)	(750)
Payments to seller for acquisition		(196)
Net cash provided by financing activities	160	1,892
Net (decrease) increase in cash, cash equivalents and restricted cash	(317)	2,277
Cash, cash equivalents and restricted cash at beginning of period	8,951	9,232
Cash, cash equivalents and restricted cash at end of period	8,634	11,509
Reconciliation of cash, cash equivalents, and restricted cash reported in the condensed consolidated balance Sheet
Cash and cash equivalents	201	729
Restricted cash	8,433	10,780
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statement of cash flows	8,634	11,509
Supplemental disclosure of cash flow information
Cash paid for interest	$ 299	$ 403